Uffe Klausen

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Dahlager Jørgensen et al. · Frontiers in Oncology · 2021 · 50 citations · Full text

The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

Shamaila Munir Ahmad, Evelina Martinenaite, Morten Orebo Holmström et al. · OncoImmunology · 2017 · 39 citations · Full text

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

Morten Orebo Holmström, Shamaila Munir Ahmad, Uffe Klausen et al. · Blood Cancer Journal · 2019 · 33 citations · Full text

Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

Nicolai Grønne Dahlager Jørgensen, Uffe Klausen, Jacob Handlos Grauslund et al. · Frontiers in Immunology · 2020 · 27 citations · Full text

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial

Jacob Handlos Grauslund, Morten Orebo Holmström, Evelina Martinenaite et al. · Frontiers in Immunology · 2023 · 12 citations · Full text